Slideshow

Medical Nutrition Therapy for Dyslipidemia: Costs and Benefits

Author(s):

Veronica Hackethal MD

Medical nutrition therapy for hyperlipidemia management is widely recommended by clinical guidelines. Is it cost-effective?

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C | Image Credit: APAC
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
Steve Nissen, MD | Credit: Cleveland Clinic
Related Content
FDA Accepts Plozasiran NDA for Familial Chylomicronemia Syndrome | Image Credit: US Food and Drug Administration
January 20th 2025

FDA Accepts Plozasiran NDA for Familial Chylomicronemia Syndrome

Connor Iapoce
Prof. Kausik Ray: Inclisiran Data at ESC Congress 2020
September 3rd 2020

Prof. Kausik Ray: Inclisiran Data at ESC Congress 2020

Patrick Campbell
Genetic Determinants of LDL-C Inversely Linked to Type 2 Diabetes Risk | Image Credit: Massachusetts General Hospital
January 15th 2025

Genetic Determinants of LDL-C Inversely Linked to Type 2 Diabetes Risk

Connor Iapoce
The State of Preventive Cardiology
August 28th 2020

The State of Preventive Cardiology

Kevin Kunzmann
Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure | Image Credit: US Food and Drug Administration
January 10th 2025

Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure

Connor Iapoce
Polypill Therapy Cost-Effective for CVD Risk in Underserved Populations | Image Credit: Sardar Faizan/Unsplash
January 8th 2025

Polypill Therapy Cost-Effective for CVD Risk in Underserved Populations

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.